abstract |
The compounds of the formula 1, wherein A, R ', R2, R3, R4a, R4b, R4c, R5, R6, R7a, R7b, Ar', Rc, Rd, Re, Rf, X, n and p have the meanings defined herein, they are inhibitors of the hepatitis C virus NS5b polymerase. Compositions and methods for treating an XCV infection and for inhibiting HCV replication are also described (see formula (I)). |